BSL >> Drug Discovery

We support you with your drug development

BSL BIOSERVICE supports your drug development project in all phases from early development to commercialization. Our services during development include Proof of concept studies (POC), ADME, IND-enabling toxicology / PK studies, immunotoxicology and immunogenicity testing. In late-phase and after market approval, we provide bioassays for batch release.

In close cooperation with our partners Eurofins BioPharma Product Testing Munich, Product Safety Labs (PSL) and Pharmacology Discovery Services our services for the biological testing of Biopharmaceuticals, Biologics and ATMPs include

Preclinical Assessment

  • Metabolism
  • Drug Interaction
  • Permeability & Transport
  • ADME in vivo (radio-labelled & non radio-labelled substances)


  • In vivo proof of concept and efficacy studies*
  • Pharmacodynamics
  • Pharmacokinetics/Toxicokinetics
  • Safety Pharmacology


  • Cytotoxicity, Phototoxicity in vitro
  • Acute Toxicity
  • Subacute, Subchronic, Chronic Toxicity
  • Carcinogenicity
  • Developmental & Reproductive Toxicity (DART)
  • Sensitization
  • Genetic Toxicology
  • Immunotoxicity
  • Immunogenicity


*We accelerate your candidate development from tailormade proof of concept studies, like infection and vaccination test designs under bio-safety level 2, and offer with our partner Pharmacology Discovery Services in Taiwan and PSL in the United States several efficacy models.